Altogether, our findings establish cIAP1 as a positive regulator of skeletal muscle atrophy and suggest that the suppression of cIAP1 could serve as a potential therapy for skeletal muscle atrophy. The gene discussed is BIRC2; the disease is Skeletal muscle atrophy.